Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

aprevo® Digital Planning

K-Number: K242599 · 2024-12-20

Decision Date2024-12-20
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

aprevo® Digital Planning is the device name listed in this FDA 510(k) record. The listed applicant is Carlsmed, Inc.. It received FDA 510(k) clearance on 2024-12-20 under 510(k) number K242599. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the aprevo® Digital Planning?

aprevo® Digital Planning is a medical device that received FDA 510(k) clearance on 2024-12-20. The listed applicant is Carlsmed, Inc.. The 510(k) number is K242599.

When did aprevo® Digital Planning receive FDA 510(k) clearance?

aprevo® Digital Planning received FDA 510(k) clearance on 2024-12-20, under 510(k) number K242599.

Who is the listed applicant for aprevo® Digital Planning?

The FDA 510(k) record lists Carlsmed, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for aprevo® Digital Planning?

The FDA product code for aprevo® Digital Planning is LLZ.

Other records listing Carlsmed, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 22 devices →

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.